Joe Cherner: ‘Pfizer and Philip Morris are both worth about $150 billion. Both pay about 4% dividend. Both trade at similar P/Es. One cures diseases for millions of people worldwide. One kills millions of people worldwide. PFE is at a yearly low. MO is trading near an all time high.’
☞ Actually, since Joe sent me that earlier in the month, PFE is up a bit – but the irony remains.
Sales seem to be on track to come in at about $2 million for the quarter just ending – down from the $20 million UBS Securities had first estimated when it set a $32 target price for the stock, and even down from the $4.7 million to which it revised its estimate (while retaining the $32 price target). As of 12/24, the 7-day rolling average for BiDil prescriptions was 131. For the week ending December 16th, according to weekly IMS data, prescriptions totaled 1082, down from 1114 the week before. Anything is possible, but – with the company currently losing about $25 million a quarter – if you bought them with money you can truly afford to lose, don’t sell your puts.
Jason Frey: ‘I used to enjoy and respect you as a financial commentator, I found your blog recently and unfortunately find it to be a monomaniacal political rant. Yikes, what happened to you?’
☞ I started believing in evolution, fiscal restraint, and the general message of the Sermon on the Mount.
Quote of the Day
To be absolutely certain about something, one must know everything or nothing about it.~Henry Kissinger
Request email delivery
- May 25:
The Truth Matters
- May 24:
The Pope: God Made You This Way
- May 23:
Travel Tip: Take Alexa WITH You?
- May 22:
Have You Already Seen This One?
- May 21:
How The Enlightenment Ends . . .
- May 18:
My Classmate Saved Stephen Hawking
- May 17:
Hi-Yo, Silver! (Unless You’re Poor)
- May 16:
Will On Pence
- May 15:
Mitch McConnell Speaks
- May 14:
From Greece To Iran
- May 25: